The internal tandem duplication (ITD) mutation of the class III receptor tyrosine kinase FMS-like Tyrosine Kinase 3 (FLT3) is found in 25% of all AML cases and is associated with a dismal prognosis [1]. Here, FLT3 is linked to acute myeloid leukemia.